THERALIGHT
Therapeutic Applications of Light-Regulated Drugs
| Coordinatore | FUNDACIO INSTITUT DE BIOENGINYERIA DE CATALUNYA
Spiacenti, non ci sono informazioni su questo coordinatore. Contattare Fabio per maggiori infomrazioni, grazie. |
| Nazionalità Coordinatore | Spain [ES] |
| Totale costo | 160˙900 € |
| EC contributo | 149˙915 € |
| Programma | FP7-IDEAS-ERC
Specific programme: "Ideas" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013) |
| Code Call | ERC-2012-PoC |
| Funding Scheme | CSA-SA(POC) |
| Anno di inizio | 2013 |
| Periodo (anno-mese-giorno) | 2013-08-01 - 2014-11-30 |
Partecipanti
| # | ||||
|---|---|---|---|---|
| 1 |
FUNDACIO INSTITUT DE BIOENGINYERIA DE CATALUNYA
Organization address
address: CARRER BALDIRI REIXAC PLANTA 2A 10-12 contact info |
ES (BARCELONA) | hostInstitution | 149˙915.00 |
Mappa
Word cloud
Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.
Obiettivo del progetto (Objective)
One of the major drawbacks of pharmacological therapies is the difficulty to control drug kinetics and restrict drug action to the target organ. This in turn limits the efficacy of drugs and triggers undesired side effects for patients. We have developed an innovative approach to control the activity of drugs with light in cell culture systems. The PoC grant will allow going a step further by testing these new methods on important pharmacological target receptors and assay them in vivo. These tests should lead to the first clinical trials and to present the biomedical applications of his project to pharmaceutical companies. The combination of drugs with external illumination devices could create a more personalised medicine where therapies could be tuned to adapt each individual patient.